Details of the Drug

General Information of Drug (ID: DM3427C)

Drug Name
PF-4427429
Synonyms PF-04427429; RI-307; Anti-CGRP antibodies (migraine), Pfizer
Indication
Disease Entry ICD 11 Status REF
Migraine 8A80 Phase 1 [1]
Cross-matching ID
TTD ID
D04JAT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcitonin gene-related peptide (CALC) TTAFORY NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01117233) Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429. U.S. National Institutes of Health.
2 Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints